Aleksandra Brzozowska

Ms. Aleksandra Brzozowska

Gdańsk Medical University, Gdańsk, Pomorskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ABAleksandra Brzozowska
Aleksandra Brzozowska
JGJakub Grabowski
Jakub Grabowski
Approximately 70% of people will experience a traumatic event in their lifetime, but post-traumatic stress disorder (PTSD) will only develop in 3.9% and complex post-traumatic stress disorder (CPTSD) in 1–8% of the population worldwide, although in some countries (e.g., Poland and Northern Ireland) it will develop in a much higher percentage. Stress-related disorders have a complex pathogenesis involving neurophysiological, genetic, epigenetic, neuroendocrine and environmental factors. This article reviews the current state of knowledge on the molecular aspects of selected PTSD symptoms: hypervigilance, re-experiencing, emotion dysregulation and dissociation, i.e., the symptoms with strong neurobiological components. Among analysed susceptibility factors are specific gene polymorphisms (e.g., FKBP5, COMT, CHRNA5, CRHR1, 5-HTTLPR, ADCY8 and DRD2) and their interactions with the environment, changes in the HPA axis, adrenergic hyperactivity and disturbances in the activity of selected anatomical structures (including the amygdala, prefrontal cortex, corpus callosum, anterior cingulate gyrus and hippocampus). It is worth noting that therapeutic methods with proven effectiveness in PTSD (TF-CBT and EMDR) have a substantial neurobiological rationale. Molecular aspects seem crucial when searching for effective screening/diagnostic methods and new potential therapeutic options.

Verified
Journal Article
Open access
PDF file
JGJakub Grabowski
Jakub Grabowski
ANAnna Niebrzydowska
Anna Niebrzydowska
ABAleksandra Brzozowska
Aleksandra Brzozowska
Przemyslaw M WaszakPrzemyslaw M Waszak
Przemyslaw M Waszak
PZPawel Zagozdzon
Pawel Zagozdzon
LBLeszek Bidzan
Leszek Bidzan
This study aimed to assess the prevalence and reporting rate of adverse events following immunization (AEFIs) among healthcare professionals (HCPs) and students of health-related disciplines after COVID-19 vaccination. It was conducted at the beginning of the vaccination campaign in Poland (February 2021), when vaccines were only available to limited groups of recipients, mainly those related to healthcare. Questionnaires were distributed among HCPs in the Pomeranian voivodeship (N = 1063) and students at the Medical University of Gdańsk (N = 1506). The primary objective was to compare respondents’ self-reported AEFI notifications with official reports published by the National Sanitary Inspectorate. A total of 240 participants declared having reported at least one AEFI, whereas official reports from the same period indicated that only 194 individuals had reported AEFIs in the entire voivodeship. This translates into significant differences in notification rates (14.9% and 0.09%, respectively). A detailed breakdown into local and systemic AEFIs also revealed significant discrepancies with official reports (850 vs. 329 and 1137 vs. 46, respectively). The most common reasons for not reporting were managing the symptoms on one’s own and perceiving the symptoms as not severe enough to report. Underreporting of AEFIs is an issue that requires attention from both the scientific community and public health authorities, as it may hinder reliable vaccine safety assessment and contribute to increased vaccine hesitancy.

13 April 2025 in Archives of Psychiatry and Psychotherapy
Verified
Journal Article
Open access
ABAleksandra Brzozowska
Aleksandra Brzozowska
JGJakub Grabowski
Jakub Grabowski
AGAleksandra Grzyb
Aleksandra Grzyb
The market for dietary supplements intended to improve mood or reduce negative effects of stress is of considerable size (estimated at $656 mln globally in 2022). In the UE 10% of people who consume dietary supplements, do it to reduce depression, stress or anxiety. The statistics are higher for women and people aged 18-44. In Poland specifically, out of 89% of adults who used dietary supplements or OTC medications in the previous year 13% chose products that affect mental health in some way. Popularity of such preparations may reflect higher prevalence of psychological distress, low availability of professional mental healthcare (i.e. psychiatrists, psychologists and psychotherapists) as well as social stigma of receiving professional treatment for mental disorders. The aim of this review was to present the current state of knowledge about the most popular herbal ingredients included in preparations advertised as mood enhancers or stress relievers. An internet search was performed to identify 10 most popular herbal ingredients found in this kind of products and collect producers’/merchants’ declarations as to the expected results. For each ingredient research was performed using PubMed, Google Scholar, Cochrane Library and Up to Date to present evidence-based-knowledge relating to mood and stress. The main conclusion is that herbs are widely used in preparations addressing psychological distress and herbal ingredients used in the mental health sector need to be thoroughly researched, both in terms of psychopharmacology and public health to identify potentially hazardous patterns of consumption and introduce proper education, if needed.

14 July 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ABAleksandra Brzozowska
Aleksandra Brzozowska
JGJakub Grabowski
Jakub Grabowski
Poland is one of the leading countries in the European Union for dietary supplement (DS) use, with a rapidly expanding market that includes products marketed for mood improvement and stress relief. Despite high levels of psychological distress in the population, detailed data on the use of these products remains limited. This study aimed to assess the prevalence and usage patterns of DS and OTC medications for mood improvement and stress relief among adults in Poland, along with factors that influence their choices and safety practices. A cross-sectional survey was conducted between October 2024 and May 2025 using an online questionnaire and in-person interviews. Respondents were classified as current users (CU), past users (PU) or never users (NU). Statistical analyses involved chi-square tests and t-tests. Of 798 respondents (80,6% women), there were 184 CU (23,06%) and 297 PU (37,22%). The most common ingredients were Withania somnifera, Melissa officinalis and melatonin. 94 CU (51,09%) and 131 PU (44,11%) reported concurrent use of regular medications, but only a small proportion of them (25,54% and 18,86%, respectively) informed their physician. Main reasons for nondisclosure included the belief that DS use is irrelevant to medical decisions and fear of judgment. CU were more likely than PU to use DS rather than OTC drugs, consider the composition when choosing a preparation and engage in long-term use (> 1 year). DS and OTC medications for mood improvement and stress relief are widely used among adults in Poland. Limited communication with healthcare providers, misconceptions about safety and potential interactions highlight the need for better patient education, improved nutrivigilance and routine screening for DS and OTC use in clinical practice.

28 August 2024 in Health Psychology Report
Verified
Journal Article
Open access
JGJakub Grabowski
Jakub Grabowski
TMTomasz Michalski
Tomasz Michalski
MBMaciej Kajetan Brosz
Maciej Kajetan Brosz
ABAleksandra Brzozowska
Aleksandra Brzozowska
GGGursimran Gaba
Gursimran Gaba
Background: As a severe and prolonged stressor, the COVID-19 pandemic has contributed to development or exacerbation of mental disorders. For substance use disorder, the link between stress and alcohol consumption is well established. However, there have been conflicting findings in the context of the pandemic. The aim of this study was to characterize the group of high-risk alcohol consumers in terms of perceived stress and potential stressors during the third wave of the pandemic.Participants and procedure: Adult Polish men (N = 295) from the Tricity metropolitan area participated in the study. They were subdivided into high-risk (n = 104) and low-risk (n = 191) alcohol consumers based on their self-reported weekly alcohol consumption. A demograph-ic survey (including COVID-19 vaccination status), the Perceived Stress Scale (PSS-10) and an original questionnaire meas-uring causes of concern were used.Results: Overall PSS-10 results did not differ significantly between high-risk and low-risk alcohol consumers (18.40, 17.50, respec-tively, p = .185). However, the percentage distribution of perceived stress showed lower incidence of low and high levels of stress in high-risk than in low-risk alcohol consumers (9.6%, 2.9% vs. 25.7%, 6.8%, p = .001). High-risk alcohol consumers reported no pandemic-related worries more often than low-risk consumers (46.2% vs. 5.2%, p < .001), but at the same time 67.3% of them named at least one pandemic-related stressor. High-risk alcohol consumers also showed less concern about the situation on the labor market (19.2% vs. 29.3%, p < .001). Limited access to medical services and other people’s attitudes to the pandemic were common stressors in both groups, with high-risk alcohol consumers showing more indifference to the latter.Conclusions: High-risk and low-risk alcohol consumers have been clearly impacted by pandemic-related factors. The protective effect of alcohol is debatable, given the high prevalence of medium and high stress levels among high-risk alcohol consumers. It appears that the pandemic and associated restrictions posed such a significant risk for distress escalation that they re-mained unrelated to the pattern of alcohol consumption or its alteration.

20 August 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
ABAleksandra Brzozowska
Aleksandra Brzozowska
JGJakub Grabowski
Jakub Grabowski
MBMaciej Kajetan Brosz
Maciej Kajetan Brosz
Background/Objectives: Dietary supplements (DSs) and over-the-counter (OTC) medications for mood improvement and stress relief are widely used, but little is known about how their use relates to coping preferences, trust in physicians, and communication with doctors. This exploratory cross-sectional study compared users and non-users of such products in Poland. Methods: Data were collected between October 2024 and May 2025 and included 798 adults recruited through a mixed-mode convenience sampling strategy (636 online and 162 in person). Participants were classified as current users (CUs; n = 184), past users (PUs; n = 297), or never-users (NUs; n = 317). The outcomes included hypothetical future coping strategies (under an assumption of unlimited resources), trust in physicians using an author-translated adaptation of the Trust in Doctors in General (T-DiG) scale and three-category communication-related attitudes. Multivariable models were adjusted for age, gender, education, medical or health science background, and recruitment mode. Results: Overall, 60.3% of respondents reported current or past use. Compared with NUs, both CUs and PUs had higher adjusted odds of selecting future DS/OTC use (CUs: aOR = 5.60, 95% CI 3.44–9.14, p < 0.001; PUs: aOR = 2.44, 95% CI 1.52–3.93, p < 0.001). PUs also had higher adjusted odds of selecting psychotherapy (aOR = 1.50, 95% CI 1.04–2.17, p = 0.031; overall p = 0.018). Product-use status was associated with selected items of T-DiG: communication competency (overall p = 0.031) and global trust (overall p < 0.001). Compared with NUs, CUs had lower adjusted scores on both subscales (aMD = −0.19, 95% CI −0.33 to −0.04, p = 0.010 and aMD = −0.40, 95% CI −0.59 to −0.21, p < 0.001, respectively). Overall product-group effects were also observed for the first two communication items: CUs had lower relative risk ratios than NUs for discussing product-related doubts first with their physician (RRR = 0.52, 95% CI 0.35–0.78, p = 0.001) and for feeling free to raise such doubts (RRR = 0.57, 95% CI 0.36–0.92, p = 0.022). Conclusions: Product-use status showed selective associations with hypothetical coping preferences, physician trust, and communication-related attitudes rather than a uniform pattern of reluctance to seek professional support. Current use was most strongly associated with lower trust and less favorable product-related communication attitudes. Given the cross-sectional design and hypothetical nature of the coping outcomes, these findings do not establish causality, temporal ordering, or actual healthcare-seeking behavior.